The stock of Baxter International Inc (NYSE: BAX) has increased by 2.64 when compared to last closing price of 29.93. Despite this, the company has experienced a -1.44% fall in its stock price over the last five trading sessions. businesswire.com reported 2025-05-06 that DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagn.
Is It Worth Investing in Baxter International Inc (NYSE: BAX) Right Now?
BAX has 36-month beta value of 0.63. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 11 as “hold,” and 1 as “sell.”
The public float for BAX is 508.23M, and currently, short sellers hold a 3.40% ratio of that float. The average trading volume of BAX on May 08, 2025 was 5.01M shares.
BAX’s Market Performance
The stock of Baxter International Inc (BAX) has seen a -1.44% decrease in the past week, with a 7.26% rise in the past month, and a -2.38% fall in the past quarter. The volatility ratio for the week is 3.76%, and the volatility levels for the past 30 days are at 4.44% for BAX. The simple moving average for the past 20 days is 3.76% for BAX’s stock, with a -9.13% simple moving average for the past 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Goldman repeating the rating for BAX by listing it as a “Buy.” The predicted price for BAX in the upcoming period, according to Goldman is $42 based on the research report published on February 26, 2025 of the current year 2025.
Barclays gave a rating of “Overweight” to BAX, setting the target price at $39 in the report published on February 20th of the current year.
BAX Trading at -4.35% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.13% of loss for the given period.
Volatility was left at 4.44%, however, over the last 30 days, the volatility rate increased by 3.76%, as shares surge +9.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.52% lower at present.
During the last 5 trading sessions, BAX fell by -1.44%, which changed the moving average for the period of 200-days by -13.10% in comparison to the 20-day moving average, which settled at $29.61. In addition, Baxter International Inc saw 5.35% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BAX starting from Stevens Brian, who proposed sale 976 shares at the price of $40.01 back on Sep 16 ’24. After this action, Stevens Brian now owns shares of Baxter International Inc, valued at $39,046 using the latest closing price.
Stevens Brian, the Officer of Baxter International Inc, proposed sale 16,063 shares at $39.81 during a trade that took place back on Sep 13 ’24, which means that Stevens Brian is holding shares at $639,465 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.36 for the gross margin
The net margin for Baxter International Inc stands at -0.03. The total capital return value is set at -0.03. Equity return is now at value -9.24, with -2.63 for asset returns.
Based on Baxter International Inc (BAX), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 1.93. The interest coverage ratio of the stock is -1.44.
Currently, EBITDA for the company is -112.0 million with net debt to EBITDA at 54.6. When we switch over and look at the enterprise to sales, we see a ratio of 2.31. The receivables turnover for the company is 6.87for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
To put it simply, Baxter International Inc (BAX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
